Globus Medical, Inc. (GMED)
- Previous Close
70.60 - Open
70.38 - Bid 69.37 x 800
- Ask 73.50 x 800
- Day's Range
69.80 - 70.70 - 52 Week Range
43.39 - 74.21 - Volume
611,292 - Avg. Volume
866,744 - Market Cap (intraday)
9.565B - Beta (5Y Monthly) 1.18
- PE Ratio (TTM)
353.20 - EPS (TTM)
0.20 - Earnings Date Nov 5, 2024 - Nov 11, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
79.31
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
www.globusmedical.comRecent News: GMED
View MorePerformance Overview: GMED
Trailing total returns as of 9/20/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: GMED
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: GMED
View MoreValuation Measures
Market Cap
9.57B
Enterprise Value
9.60B
Trailing P/E
353.20
Forward P/E
20.92
PEG Ratio (5yr expected)
1.90
Price/Sales (ttm)
4.17
Price/Book (mrq)
2.41
Enterprise Value/Revenue
4.29
Enterprise Value/EBITDA
24.25
Financial Highlights
Profitability and Income Statement
Profit Margin
1.82%
Return on Assets (ttm)
6.11%
Return on Equity (ttm)
1.37%
Revenue (ttm)
2.24B
Net Income Avi to Common (ttm)
40.67M
Diluted EPS (ttm)
0.20
Balance Sheet and Cash Flow
Total Cash (mrq)
492.93M
Total Debt/Equity (mrq)
13.35%
Levered Free Cash Flow (ttm)
-227.96M